UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000030206
Receipt No. R000034306
Scientific Title Randomized phase II study of osimertinib plus bevacizumab and osimertinib for chemotherapy-naive patients with nonsquamous non-small cell lung cancer harboring EGFR mutations (investigator-initiated multicenter clinical trial, WJOG9717L)
Date of disclosure of the study information 2017/12/01
Last modified on 2018/10/29 11:22:32

No. Disposal Last modified on Item of update
1 Insert 2017/12/01 09:41:54
2 Update 2017/12/01 09:46:37 Public title
3 Update 2018/06/03 12:33:29 Anticipated trial start date
4 Update 2018/06/04 09:09:29 Recruitment status
5 Update 2018/10/29 11:22:32 Recruitment status

Contact us.